LNP Formulation

Our non-viral delivery platform leverages state-of-the-art materials science to enable efficient RNA delivery to target cells. We design lipid nanoparticle (LNP) formulations for optimal in vitro and in vivo RNA delivery, with the ability to customize formulations and screen unique variants based on our customers’ needs.

We understand the unique delivery challenges associated with developing RNA-based therapeutics, including encapsulation efficiency, stability, biodistribution, target tissue uptake, endosomal escape and immunogenicity. By leveraging our broad experience across different therapeutic areas, we can create tailored LNP formulations that address these challenges, providing an ideal delivery solution for initial proof-of-concept studies and beyond.

We have supplied customers with LNP products & services across various research applications:

• In vitro/in vivo gene editing

• High throughput in vitro CRISPR screens

• In vivo biodistribution studies

• mRNA vaccine discovery

Speak to our team of experts about RNA delivery solutions for your research application. We can accommodate all kinds of RNA modalities, including mRNAs, lncRNAs, siRNAs and ASOs.